FDA Inspection 893493 — Hans Biomed Corporation
The FDA completed an inspection of Hans Biomed Corporation on Jun 3, 2014 in Yuseong District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 3, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Yuseong District (Korea (the Republic of))